首页> International immunopharmacology> Sakuranetin inhibits osteoclastogenesis and rescues the ovariectomy-induced bone loss by blocking PI3K/AKT and NF-κB signaling pathway.

Sakuranetin inhibits osteoclastogenesis and rescues the ovariectomy-induced bone loss by blocking PI3K/AKT and NF-κB signaling pathway.

导出 LinkOut

翻译打印收藏纠错

第一作者： Beiduo,Shen

第一单位： Department of Spine Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China.

作者： Beiduo,Shen ^[1] ; YingYing,Du ^[2] ; Runqi,Wang ^[2] ; Yifeng,Zhang ^[1] ; Yang,Cao ^[1] ; Li,Zhao ^[1] ; Bing,Zhou ^[3] ; Liye,Yang ^[4] ; Ziqi,Zhu ^[5]

作者单位： Department of Spine Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China. ^[1] Department of Orthopedics, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China. ^[2] Department of Orthopedics, Gaoyou People's Hospital, Gaoyou 225600, Jiangsu, China. Electronic address: 876870015@qq.com. ^[3] Department of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China. Electronic address: yangliye1204@163.com. ^[4] Department of Spine Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China. Electronic address: spinexman@163.com. ^[5]

关键词 NF-κB Osteoclast Osteoporosis PI3K/AKT Sakuranetin